Geode Capital Management’s Lixte Biotechnology LIXT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Sell |
20,704
-2,337
| -10% | -$2.11K | ﹤0.01% | 4369 |
|
|
2025
Q1 | $27.9K | Buy |
23,041
+6,175
| +37% | +$7.47K | ﹤0.01% | 4291 |
|
|
2024
Q4 | $35.4K | Sell |
16,866
-295
| -2% | -$619 | ﹤0.01% | 4298 |
|
|
2024
Q3 | $33.5K | Buy |
+17,161
| New | +$33.5K | ﹤0.01% | 4338 |
|
|
2023
Q3 | – | Sell |
-10,119
| Closed | -$59K | – | 4772 |
|
|
2023
Q2 | $59K | Sell |
10,119
-91,090
| -90% | -$531K | ﹤0.01% | 4469 |
|
|
2023
Q1 | $84K | Buy |
101,209
+75,415
| +292% | +$62.6K | ﹤0.01% | 4396 |
|
|
2022
Q4 | $13K | Hold |
25,794
| – | – | ﹤0.01% | 4819 |
|
|
2022
Q3 | $14K | Hold |
25,794
| – | – | ﹤0.01% | 4954 |
|
|
2022
Q2 | $19K | Sell |
25,794
-15,179
| -37% | -$11.2K | ﹤0.01% | 4929 |
|
|
2022
Q1 | $49K | Buy |
40,973
+315
| +0.8% | +$377 | ﹤0.01% | 4807 |
|
|
2021
Q4 | $48K | Buy |
40,658
+3,142
| +8% | +$3.71K | ﹤0.01% | 4868 |
|
|
2021
Q3 | $78K | Buy |
+37,516
| New | +$78K | ﹤0.01% | 4718 |
|